Overview of Adjuvant and Neoadjuvant Therapy for Resectable Gastric Cancer in the East

Publisher： Karger

E-ISSN： 1421-9883|30|2|119-129

ISSN： 0253-4886

Source： Digestive Surgery, Vol.30, Iss.2, 2013-07, pp. : 119-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Re: Survival after Neoadjuvant Therapy Compared with Surgery Alone for Resectable Esophageal Cancer in a Population Based Study

By Peters Jeffrey  

World Journal of Surgery, Vol. 30, Iss. 12, 2006-12 ,pp. : 2191-2192

Springer Publishing Company

Access to resources Recommend Favorite

Survival After Neoadjuvant Therapy Compared with Surgery Alone for Resectable Esophageal Cancer in a Population-based Study

By Rouvelas Ioannis   Zeng Wenyi   Lindblad Mats   Viklund Pernilla   Ye Weimin   Lagergren Jesper  

World Journal of Surgery, Vol. 30, Iss. 12, 2006-12 ,pp. : 2182-2190

Springer Publishing Company

Access to resources Recommend Favorite

Lymph Node Dissection in Resectable Advanced Gastric Cancer

By  

Digestive Surgery, Vol. 30, Iss. 2, 2013-07 ,pp. : 96-103

Karger

Access to resources Recommend Favorite

(Neo)-Adjuvant Chemo(-Radio) Therapy for Adenocarcinomas of the Gastroesophageal Junction and the Stomach in the West

By  

Digestive Surgery, Vol. 30, Iss. 2, 2013-07 ,pp. : 112-118

Karger

Access to resources Recommend Favorite

Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer

By  

Digestive Surgery, Vol. 32, Iss. 4, 2015-05 ,pp. : 229-237

Karger

Access to resources Recommend Favorite